InvestorsHub Logo
Followers 15
Posts 1505
Boards Moderated 0
Alias Born 03/30/2021

Re: Skiluc post# 6317

Tuesday, 06/08/2021 4:54:17 PM

Tuesday, June 08, 2021 4:54:17 PM

Post# of 13742
Granted. But they had no choice but to raise the A/S to be able to pay off this note. They'll also need to raise money to conduct clinical trials, if in fact Escozine is approved for IND status. We might see more noteholders if it does get approved. But there's no hiding it, they are diluting. But they do at least have decent reasons to raise capital.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.